A narrative exploration of psilocybin’s potential in mental health
Jisu Park, Taejung Kim, Han-Tsung Min, Soon-Young Park, S. Na, H. Lee, Jaap Ham, Yejin Park
Frontiers in Psychiatry October 30, 2024 DOI: 10.3389/fpsyt.2024.1429373 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Hallucinogen Mental health Psychotherapist Distress Mainstream |
| Citations | 4 |
| Key findings | Psilocybin is safe in clinical trials with manageable side effects, but additional safety measures are required. |
Abstract
Psilocybin, a psychoactive substance, has recently garnered attention for its high therapeutic potential in psychiatry. In this study, we investigated the multifaceted aspects of psilocybin, highlighting its chemical properties, mechanisms of action, and burgeoning role in psychiatric treatment. Furthermore, we examined the clinical applications and potential therapeutic benefits of psilocybin in the treatment of various mental health disorders, supported by accumulating clinical evidence. This review aims to deepen our understanding of the clinical impact of psilocybin, elucidate its therapeutic value, and propose directions for future research, thereby paving the way for its integration into mainstream psychiatric treatments. Psilocybin has been shown to be safe in clinical trials with manageable side effects. However, additional safety measures are required after this discussion, including dosing protocols, patient monitoring, and distress management strategies.